Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NUS Stock Forecast 2026-2027
$5.47
Current Price
$265.57M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to NUS Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
NUS Price Momentum
+2.8%
1 Week Change
-10.6%
1 Month Change
-27.6%
1 Year Change
-43.1%
Year-to-Date Change
-62.6%
From 52W High of $14.62
+5.4%
From 52W Low of $5.19
📊 TOP ANALYST CALLS
Did NUS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Nu Skin is one of their latest high-conviction picks.
Latest NUS Stock Price Targets & Analyst Predictions
NUS has shown a year-to-date change of -43.1% and a 1-year change of -27.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for NUS. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NUS Analyst Ratings
0
Buy
0
Hold
0
Sell
NUS Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $5.47
Latest NUS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NUS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $7.00 |
| Oct 22, 2024 | Citigroup | Neutral | Maintains | $N/A | |
| Aug 12, 2024 | DA Davidson | Neutral | Maintains | $N/A | |
| Aug 9, 2024 | Citigroup | Neutral | Maintains | $N/A | |
| May 9, 2024 | DA Davidson | Neutral | Maintains | $N/A | |
| Jan 5, 2024 | DA Davidson | Neutral | Maintains | $N/A | |
| Oct 16, 2023 | Stifel | Hold | Maintains | $N/A | |
| Sep 29, 2023 | Citigroup | Neutral | Maintains | $N/A | |
| Aug 3, 2023 | DA Davidson | Neutral | Reiterates | $N/A | |
| Aug 2, 2023 | Stifel | Hold | Maintains | $N/A | |
| May 19, 2023 | DA Davidson | Neutral | Reiterates | $N/A | |
| Mar 1, 2023 | Citigroup | Neutral | Maintains | $N/A | |
| Feb 16, 2023 | DA Davidson | Neutral | Maintains | $N/A | |
| Jan 31, 2023 | Jefferies | Hold | Downgrade | $N/A | |
| Nov 23, 2022 | DA Davidson | Neutral | Maintains | $N/A | |
| Oct 5, 2022 | Citigroup | Neutral | Maintains | $N/A | |
| Aug 23, 2022 | DA Davidson | Neutral | Maintains | $N/A | |
| Aug 8, 2022 | Citigroup | Neutral | Maintains | $N/A | |
| May 5, 2022 | DA Davidson | Neutral | Maintains | $N/A | |
| Feb 17, 2022 | DA Davidson | Neutral | Maintains | $N/A |
Nu Skin Enterprises Inc. (NUS) Competitors
The following stocks are similar to Nu Skin based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nu Skin Enterprises Inc. (NUS) Financial Data
Nu Skin Enterprises Inc. has a market capitalization of $265.57M with a P/E ratio of 5.0x. The company generates $1.44B in trailing twelve-month revenue with a 3.8% profit margin.
Revenue growth is -12.0% quarter-over-quarter, while maintaining an operating margin of +1.8% and return on equity of +7.0%.
Valuation Metrics
Market Cap
$265.57M
Enterprise Value
$366.96M
P/E Ratio
5.0x
PEG Ratio
-0.1x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
-12.0%
Gross Margin
+66.9%
Operating Margin
+1.8%
Net Margin
+3.8%
EPS Growth
-98.3%
Financial Health
Cash/Price Ratio
+75.5%
Current Ratio
2.0x
Debt/Equity
38.2x
ROE
+7.0%
ROA
+3.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Nu Skin Enterprises Inc. (NUS) Business Model
About Nu Skin Enterprises Inc.
What They Do
Direct selling of personal care products and supplements.
Business Model
The company operates a direct selling model that empowers individuals to run their own businesses by selling a range of beauty and wellness products. Nu Skin generates revenue through the sale of premium-quality personal care products and dietary supplements, leveraging innovative product development and an entrepreneur-focused sales strategy.
Additional Information
Founded in 1984 and based in Provo, Utah, Nu Skin has expanded its operations globally and is recognized for its commitment to quality and sustainability. The company integrates scientific research into its products and maintains a strong presence in the competitive direct selling industry.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
3,100
CEO
Mr. Ryan S. Napierski
Country
United States
IPO Year
1996
Website
www.nuskin.comNu Skin Enterprises Inc. (NUS) Latest News & Analysis
Latest News
Quick Summary
Price-to-sales screens can identify undervalued growth opportunities, especially when earnings are low, by combining low P/S ratios with balance-sheet and value assessments.
Why It Matters
The excerpt highlights a strategy for identifying undervalued growth stocks, suggesting that low price-to-sales ratios combined with solid financials may signal potential investment opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The June GVAS portfolio identifies 13 large-cap value stocks with strong dividends and positive cash flow. The top ten are expected to gain an average of 39.68% by June 2027, with yields between 7.9% and 16.46%.
Why It Matters
The GVAS portfolio indicates strong potential returns and high dividend yields in large-cap value stocks, particularly in energy and financial sectors, signaling attractive investment opportunities.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Stocks SCVL, NUS, APLE, COP, and FAF are identified as undervalued based on low price-to-sales ratios, supported by favorable debt levels, strong cash flow, and positive business momentum.
Why It Matters
Low price-to-sales stocks indicate potential buying opportunities, driven by manageable debt, robust cash flow, and positive business trends, suggesting strong future performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
EL, NUS, and COTY are leveraging AI and wellness trends to adapt to evolving beauty demand in skincare, cosmetics, and fragrance sectors.
Why It Matters
The focus on AI and wellness by EL, NUS, and COTY indicates a shift in beauty trends, potentially driving growth and market share in skincare, cosmetics, and fragrance, impacting stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
30 days ago
Quick Summary
Nu Skin Enterprises has provided 900 million meals for malnourished children globally since 2002 through its Nourish the Children initiative, benefiting over 65 countries.
Why It Matters
Nu Skin's achievement of providing 900 million meals enhances its corporate social responsibility profile, potentially boosting brand loyalty and attracting socially-conscious investors.
Source: Business Wire
Market Sentiment:
Neutral
Nu Skin Enterprises Q1 Earnings Call Highlights
1 month ago
Quick Summary
Nu Skin Enterprises (NYSE: NUS) reported Q1 2026 results meeting expectations, focusing on its Prysm iO wellness platform and expansion in emerging markets amid macroeconomic challenges.
Why It Matters
Nu Skin's steady performance amid macro pressures and ongoing investments in growth initiatives signals resilience, which could bolster investor confidence and impact stock valuation.
Source: MarketBeat
Market Sentiment:
Positive
Frequently Asked Questions About NUS Stock
What is Nu Skin Enterprises Inc.'s (NUS) stock forecast for 2026?
Analyst forecasts for Nu Skin Enterprises Inc. (NUS) are not currently available. The stock is trading at $5.47.
Is NUS stock a good investment in 2026?
Analyst ratings for NUS are not currently available. The stock is currently trading at $5.47. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NUS stock?
Price predictions from Wall Street analysts for NUS are not currently available. The stock is trading at $5.47.
What is Nu Skin Enterprises Inc.'s business model?
The company operates a direct selling model that empowers individuals to run their own businesses by selling a range of beauty and wellness products. Nu Skin generates revenue through the sale of premium-quality personal care products and dietary supplements, leveraging innovative product development and an entrepreneur-focused sales strategy.
What is the highest forecasted price for NUS Nu Skin Enterprises Inc.?
Price targets from Wall Street analysts for NUS are not currently available. The stock is trading at $5.47.
What is the lowest forecasted price for NUS Nu Skin Enterprises Inc.?
Price targets from Wall Street analysts for NUS are not currently available. The stock is trading at $5.47.
What is the overall NUS consensus from analysts for Nu Skin Enterprises Inc.?
Analyst ratings for NUS are not currently available. The stock is trading at $5.47.
How accurate are NUS stock price projections?
Stock price projections, including those for Nu Skin Enterprises Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 15, 2026 3:32 AM UTC